Sign in

CIK 0000842023

  • Large accelerated filer

BIO-TECHNE Corp

Sign in to watch
Ticker
TECH
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
MN
Entity type
Operating
EIN
411427402
Phone
+1 612-379-8854
Business address
614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
Former names
TECHNE CORP /MN/
  1. 4 Shares withheld for taxes Pres. Diagnostics & Genom gave up 4,139 shares (to pay taxes)
  2. 4 Planned sale Chief Executive Officer sold 80,000 shares at $88.36 ($7,069,024)
  3. 4 Shares withheld for taxes Chief Executive Officer gave up 390,727 shares (to pay taxes)
  4. 4 Open-market sale Chief Executive Officer sold 322 shares at $83.00 ($26,726)
  5. 4 Shares withheld for taxes Director gave up 4,377 shares (to pay taxes)
  6. 4 Gift Director gave 377 shares (gift)
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Shares withheld for taxes Chief Executive Officer gave up 255,837 shares (to pay taxes)
  10. 4 Open-market sale SVP - GENERAL COUNSEL sold 8,250 shares at an average $82.11 ($677,415)
  11. 4 Grant or award Director acquired 338 shares (grant or award)
  12. 4 Grant or award Director acquired 338 shares (grant or award)
  13. 4 Grant or award Director acquired 338 shares (grant or award)
  14. 4 Grant or award Director acquired 338 shares (grant or award)
  15. 4 Grant or award Director acquired 338 shares (grant or award)
  16. 4 Grant or award Director acquired 338 shares (grant or award)
  17. 4 Grant or award Director acquired 338 shares (grant or award)
  18. 4 Grant or award Director acquired 338 shares (grant or award)
  19. 4/A Derivatives Options or other derivatives
  20. 4 Option exercise Pres. Diagnostics & Genom acquired 663 shares (option exercise)

Page 8 of 35 · 695 filings